Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA Partnering is Open for Business
The CMTA is a global leader in the acceleration of CMT research and pre-clinical testing. The CMTA team will be attending the PNS annual meeting in Copenhagen and have availability…
CMTA Adds Science Writer Kenneth Raymond to Team
…for patients and their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with…
CMTA to attend the annual BIO partnering conference in Boston
The CMTA is a global leader in the acceleration of CMT research and pre-clinical testing. The CMTA will be attending the BIO annual meeting in Boston and have availability for…
New Gene Therapy Development Program for CMT2A
…that it has licensed a sixth gene therapy development program under its research, collaboration and license agreement with the University of Pennsylvania and its Gene Therapy Program (GTP). The license…
CMTA Announces New Center of Excellence at Duke University Hospital
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is thrilled…
Regenacy Pharmaceuticals Announces Collaboration with the CMTA to Advance Ricolinostat for the Treatment of Hereditary Neuropathy
…Neuropathy Clinics and Cutaneous Innervation Laboratory in the Department of Neurology at the University of Rochester, and a member of the STAR (Strategy to Accelerate Research) advisory board for the…
CMTA-Funded Study on 3-D Printing Technique for Comparing CMT Heel Surgeries Named Game Changer at AAOS Meeting
…the second phase of the research to see what type of reconstructive procedure is best. That research should be completed in six months. One in 2,500 people has the genetic…